|Bid||14.18 x 0|
|Ask||14.19 x 0|
|Day's Range||13.15 - 14.60|
|52 Week Range||4.93 - 35.04|
|Beta (5Y Monthly)||3.26|
|PE Ratio (TTM)||N/A|
|Earnings Date||Feb. 11, 2021 - Feb. 15, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||11.70|
Yahoo Finance’s Alexis Christoforous and Chris Beals, CEO of WM Holding Co., the parent company of Weedmaps, discuss what Democratic control of Congress could mean for the cannabis industry.
Aurora Cannabis (NYSE: ACB) and Tilray (NASDAQ: TLRY) were among a handful of international marijuana producers chosen to participate in a new French medical marijuana experiment. The National Agency for Medicines and Health Products Safety (ANSM) is trialing a small-scale, 18- to 24-month program to supply patients with medical marijuana free of charge. Partnering with a France-based pharmaceutical establishment, producers will supply up to 3,000 patients with free product while complying with pharmaceutical standards, including Good Manufacturing Practices (GMP).
Today we will run through one way of estimating the intrinsic value of Aurora Cannabis Inc. ( TSE:ACB ) by estimating...